- Home
- THRY vs EYPT Comparison
THRY vs EYPT Comparison
Compare THRY & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRY
- EYPT
- Stock Information
- Founded
- THRY 2012
- EYPT 1987
- Country
- THRY United States
- EYPT United States
- Employees
- THRY N/A
- EYPT N/A
- Industry
- THRY Industrial Machinery/Components
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- THRY Industrials
- EYPT Industrials
- Exchange
- THRY Nasdaq
- EYPT Nasdaq
- Market Cap
- THRY 594.8M
- EYPT 484.4M
- IPO Year
- THRY 2020
- EYPT 2005
- Fundamental
- Price
- THRY $12.06
- EYPT $10.19
- Analyst Decision
- THRY Strong Buy
- EYPT Strong Buy
- Analyst Count
- THRY 5
- EYPT 8
- Target Price
- THRY $21.40
- EYPT $24.75
- AVG Volume (30 Days)
- THRY 326.3K
- EYPT 906.3K
- Earning Date
- THRY 07-31-2025
- EYPT 08-06-2025
- Dividend Yield
- THRY N/A
- EYPT N/A
- EPS Growth
- THRY N/A
- EYPT N/A
- EPS
- THRY N/A
- EYPT N/A
- Revenue
- THRY $771,903,000.00
- EYPT $56,042,000.00
- Revenue This Year
- THRY N/A
- EYPT N/A
- Revenue Next Year
- THRY N/A
- EYPT N/A
- P/E Ratio
- THRY N/A
- EYPT N/A
- Revenue Growth
- THRY N/A
- EYPT 12.04
- 52 Week Low
- THRY $10.03
- EYPT $3.91
- 52 Week High
- THRY $20.92
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- THRY 32.91
- EYPT 71.73
- Support Level
- THRY $12.10
- EYPT $7.94
- Resistance Level
- THRY $12.66
- EYPT $10.77
- Average True Range (ATR)
- THRY 0.43
- EYPT 0.70
- MACD
- THRY -0.15
- EYPT 0.09
- Stochastic Oscillator
- THRY 6.52
- EYPT 83.39
About THRY Thryv Holdings Inc.
Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.